QLYS Form 144 Filed — 1,590 RSUs Proposed Sale, Recent 10b5-1 Sales Disclosed
Rhea-AI Filing Summary
Qualys, Inc. insider notice reports a proposed sale of 1,590 common shares (restricted stock units) through Morgan Stanley Smith Barney, with an aggregate market value of $211,629.00. The securities were acquired as RSUs on 08/01/2025 and the planned approximate sale date is 08/20/2025 on NASDAQ. The filer also recorded two recent 10b5-1 sales by Bruce K. Posey: 541 shares on 07/21/2025 for $75,800.02 and 525 shares on 06/20/2025 for $71,379.78. Total shares outstanding noted: 36,095,879.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale notice reporting RSU disposition and recent 10b5-1 transactions; amounts appear immaterial to cap table.
This Form 144 documents a proposed sale of 1,590 RSU-derived common shares through a broker and discloses two recent 10b5-1 program sales totaling 1,066 shares and roughly $147k in proceeds. Compared with the reported outstanding share count (36.1 million), the transactions represent a very small fraction of equity, suggesting limited immediate market impact. Compliance representation and 10b5-1 reliance are noted.
TL;DR: Disclosure aligns with Rule 144 and 10b5-1 protocols; no material governance signal evident from quantities disclosed.
The filing identifies the nature of the acquisition as restricted stock units awarded by the issuer and confirms the broker and planned exchange. The inclusion of the seller's 10b5-1 plan sales and the statutory representation about material nonpublic information are standard. Given the small size relative to total shares outstanding, these transactions do not indicate a change in control or governance concern.